FinanceTransformative Gilead Acquisition of Tubulis Signals Oncology Power PlayGilead’s $5 billion acquisition of German biotech Tubulis for oncology expansion is a transformative move, bolstering it…David Hale·April 8, 2026, 10:00 AM